Consensus Boston Scientific Corporation

Equities

BSX

US1011371077

Market Closed - Nyse Other stock markets 04:00:02 2024-06-06 pm EDT			5-day change	1st Jan Change
76.12 ^USD	+0.30%		+1.49%	+31.67%

Jun. 03	Boston Scientific Insider Sold Shares Worth $526,029, According to a Recent SEC Filing	MT
May. 31	Boston Scientific Insider Sold Shares Worth $4,791,447, According to a Recent SEC Filing	MT

Evolution of the average Target Price on Boston Scientific Corporation

Price target over the last 5 years

History of analyst recommendation changes

3b6f5ddefdd826be3f6ee781e7c9.W0bOpWQMS4SSaO_bP-XXbUwy2at4-sR8FAdwuw-l37I.NCWh_wE6ItDfPdfibIa0PHVBusMUn4EzbjVI8Tr2usAIDr31KGAU3dggpg~6eb41930432d2aef02ab902dbc23a211

Analyst Recommendations on Boston Scientific Corporation

Boston Scientific Insider Sold Shares Worth $526,029, According to a Recent SEC Filing	Jun. 03	MT
Boston Scientific Insider Sold Shares Worth $4,791,447, According to a Recent SEC Filing	May. 31	MT
Argus Adjusts Price Target on Boston Scientific to $95 From $80	May. 28	MT
Boston Scientific Insider Sold Shares Worth $2,504,239, According to a Recent SEC Filing	May. 23	MT
Citigroup Adjusts Price Target on Boston Scientific to $87 From $85, Keeps Buy Rating	May. 22	MT
CL King Adjusts Price Target on Boston Scientific to $90 From $82	May. 21	MT
Mizuho Adjusts Price Target on Boston Scientific to $90 From $85, Keeps Buy Rating	May. 15	MT
Boston Scientific Insider Sold Shares Worth $958,717, According to a Recent SEC Filing	May. 13	MT
Boston Scientific Insider Sold Shares Worth $286,874, According to a Recent SEC Filing	May. 08	MT
Boston Scientific Insider Sold Shares Worth $1,257,488, According to a Recent SEC Filing	May. 02	MT
Boston Scientific Insider Sold Shares Worth $499,075, According to a Recent SEC Filing	May. 02	MT
Boston Scientific Insider Sold Shares Worth $719,562, According to a Recent SEC Filing	Apr. 29	MT
Daiwa Adjusts Price Target on Boston Scientific to $81 From $73	Apr. 26	MT
Redburn Atlantic Adjusts Price Target on Boston Scientific to $79 From $75	Apr. 26	MT
UBS Raises Boston Scientific's Price Target to $90 From $74, Maintains Buy Rating	Apr. 25	MT
Oppenheimer Adjusts Boston Scientific's Price Target to $77 From $68	Apr. 25	MT
Bernstein Adjusts Boston Scientific Price Target to $86 From $75	Apr. 25	MT
Deutsche Bank Adjusts Price Target on Boston Scientific to $73 From $63	Apr. 25	MT
Baird Adjusts Price Target on Boston Scientific to $84 From $79	Apr. 25	MT
JPMorgan Adjusts Price Target on Boston Scientific to $82 From $72	Apr. 25	MT
Raymond James Adjusts Boston Scientific Price Target to $85 From $73	Apr. 25	MT
Wolfe Research Adjusts Boston Scientific Price Target to $81 From $72	Apr. 25	MT
CL King Adjusts Boston Scientific's Price Target to $82 From $72	Apr. 25	MT
Canaccord Genuity Adjusts Price Target on Boston Scientific to $83 From $81	Apr. 25	MT
Barclays Adjusts Boston Scientific's Price Target to $78 From $70	Apr. 25	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

76.12 USD

Average target price

82.06 USD

Spread / Average Target

+7.81%

High Price Target

90 USD

Spread / Highest target

+18.23%

Low Price Target

70 USD

Spread / Lowest Target

-8.04%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Boston Scientific Corporation

Argus
Citigroup
CL King
Mizuho Securities
Daiwa Securities
Redburn Atlantic
Barclays
Wells Fargo Securities
Canaccord Genuity
Wolfe Research
Raymond James
JPMorgan Chase
Baird
Deutsche Bank Securities
Bernstein
Oppenheimer
UBS
Truist Securities
Needham & Co.
RBC Capital Markets
BTIG
Morgan Stanley
Evercore ISI
Jefferies & Co.
Stifel Nicolaus
Piper Sandler
Nephron Research
TD Cowen
Goldman Sachs
BofA Securities
SVB Leerink
Credit Suisse
Atlantic Equities

Ratings for Boston Scientific Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar